Bovine surfactant

PreclinicalSmall molecule

Bovine surfactant is one of 5 small molecule programs targeting Meconium Aspiration Syndrome. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Meconium Aspiration SyndromeActive, not recruiting

Meconium Aspiration SyndromePreclinical

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Meconium Aspiration Syndrome

#DrugCompanyPhaseTrials

Viagra

VViatris Specialty LLC

Approved

1 2

Surfaxin

LLees Hk

Phase 3

1 3

Cafcit

KKaken Pharmaceutical

Phase 2

1 4

Decadron

AAspen Global Incorporated

Preclinical

1 5

Bovine surfactant

LLady Hardinge Medical College

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Meconium Aspiration Syndrome2 trials

Comparison Of Surfactant Lung Lavage With Standard Care In The Treatment Of Meconium Aspiration Syndrome

Completed·LLady Hardinge Medical College·N/A·NCT01310621·60 enrolled

Early Bolus Surfactant Replacement Therapy Versus Standard Care in Term Neonates With Meconium Aspiration Syndrome

Completed·LLady Hardinge Medical College·N/A·NCT06090981·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Bovine surfactant. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bovine surfactant compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bovine surfactant. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Lady Hardinge Medical College company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: LLady Hardinge Medical College

Bovine surfactant

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Meconium Aspiration Syndrome2 trials

References

Drug Info

Quick Facts

Related News